| Trial ID: | L0061 |
| Source ID: | NCT01006889
|
| Associated Drug: |
Exenatide
|
| Title: |
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01006889/results
|
| Conditions: |
Nonalcoholic Fatty Liver Disease|Type 2 Diabetes Mellitus
|
| Interventions: |
Drug: Exenatide
|
| Outcome Measures: |
Hepatic Steatosis|A1c|Change in Anthropometric Variables (Weight).|Number of Severe Hypoglycemic (Glucose ???40 mg/dL) Events.|Insulin Secretion (Hyperglycemic Clamp)|Percent Change From Baseline in Glucose Infusion (M Value) During Hyperglycemic Clamp|Lipid Profiles, Lipoprotein Analysis by NMR (LipoScience).|Change in Anthropometric Variables (BMI).
|
| Sponsor/Collaborators: |
University of Florida|Amylin Pharmaceuticals, LLC.
|
| Gender: |
All
|
| Age: |
18 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 4
|
| Enrollment: |
24
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
January 2008
|
| Completion Date: |
February 2010
|
| Results First Posted: |
July 29, 2016
|
| Last Update Posted: |
September 28, 2016
|
| Locations: |
The University of Texas H.S.C. at San Antonio and the San Antonio Audie L. Murphy VA Hospital, San Antonio, Texas, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01006889
|
